Literature DB >> 28866833

Voriconazole-induced periostitis deformans: serial imaging in a patient with ANCA vasculitis.

S Cormican1, N Adams2, P O'Connell3, A McErlean2, D de Freitas1.   

Abstract

OBJECTIVES: A 61-year-old with acute granulomatosis and polyangiitis developed Aspergillus fumigatus pneumonia after admission to the intensive care unit with a small bowel perforation. This occurred after immunosuppression (intravenous methylprednisolone, intravenous cyclophosphamide, and plasmapheresis) for his initial presentation with stage 3 acute kidney injury.
MATERIALS AND METHODS: The mycologist recommended long-term treatment with voriconazole after initial recovery.
RESULTS: After 7 months of treatment, the patient complained of joint pain and swelling in his hands. Radiographs, computed tomography, and single-photon emission computed tomography appearances were consistent with periostitis. A diagnosis of Voriconazole-induced periostitis deformans was made and the voriconazole was stopped. Plasma fluoride level was 278 μg/L (normal range < 50 μg/L). Discontinuation of voriconazole led to clinical improvement.
CONCLUSIONS: Periostitis deformans due to fluorosis is a rare complication of voriconazole treatment. The imaging in our case is unusually dramatic. We were able to track the evolution of periosteal reactions over serial imaging.

Entities:  

Keywords:  ANCA; Bone; Fluoride; Fluorosis; Periostitis deformans; SPECT-CT; Serial imaging; Skeletal; Vasculitis; Voriconazole

Mesh:

Substances:

Year:  2017        PMID: 28866833     DOI: 10.1007/s00256-017-2764-9

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  8 in total

1.  Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.

Authors:  Robert A Wermers; Kay Cooper; Raymund R Razonable; Paul J Deziel; Gary M Whitford; Walter K Kremers; Thomas P Moyer
Journal:  Clin Infect Dis       Date:  2011-01-16       Impact factor: 9.079

Review 2.  Medication-induced periostitis in lung transplant patients: periostitis deformans revisited.

Authors:  Lina Chen; Michael E Mulligan
Journal:  Skeletal Radiol       Date:  2010-07-22       Impact factor: 2.199

3.  Case 215: voriconazole-induced periostitis.

Authors:  Tina D Tailor; Michael L Richardson
Journal:  Radiology       Date:  2015-03       Impact factor: 11.105

4.  Voriconazole-induced periostitis in two post-transplant patients.

Authors:  Matthew D Bucknor; Andrew J Gross; Thomas M Link
Journal:  J Radiol Case Rep       Date:  2013-08-01

5.  Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.

Authors:  T F Wang; T Wang; R Altman; P Eshaghian; J P Lynch; D J Ross; J A Belperio; S S Weigt; R Saggar; A Gregson; B Kubak; R Saggar
Journal:  Am J Transplant       Date:  2009-10-21       Impact factor: 8.086

6.  Voriconazole-induced periostitis in a patient with overlap syndromes.

Authors:  Keisho Hirota; Akihiro Yasoda; Toshihito Fujii; Nobuya Inagaki
Journal:  BMJ Case Rep       Date:  2014-03-05

7.  Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.

Authors:  Heather S Gladue; David A Fox
Journal:  J Clin Rheumatol       Date:  2013-12       Impact factor: 3.517

8.  Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

Authors:  Bernhard Gerber; Roman Guggenberger; David Fasler; Gayathri Nair; Markus G Manz; Georg Stussi; Urs Schanz
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

  8 in total
  3 in total

1.  Painful swelling of the index finger.

Authors:  John D Fitzpatrick; Nikhil Patel; Madhvi Patel
Journal:  Skeletal Radiol       Date:  2022-03-17       Impact factor: 2.128

2.  Spectrum of voriconazole-associated periostitis in clinical characteristics, diagnosis and management.

Authors:  Zuojun Li; Cuifang Wu; Chunjiang Wang; Zhenzhen Deng
Journal:  Infection       Date:  2022-03-14       Impact factor: 7.455

Review 3.  The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors.

Authors:  Jingxiang Zhang; Liping Li; Quanzhen Lv; Lan Yan; Yan Wang; Yuanying Jiang
Journal:  Front Microbiol       Date:  2019-04-24       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.